This is a promotional meeting organised and funded by Roche Products Ltd.

For the past decade Roche has brought together the lung cancer community to share expertise, knowledge and solutions to the ever changing treatment landscape of lung cancer. This year, in addition to the 11th annual LCEF, we will also be taking the Lung Cancer Expert Forum digital. Please join us for a series of three virtual meetings, in which we will explore various aspects of lung cancer treatment, sharing expertise from across the country.

A virtual meeting uses live, online interactive technology to allow delegates to access a meeting remotely. You can join the online presentations and ask text-based questions to be answered in the Q&A session at the end of each meeting.

This is an innovative way to learn about recent developments in treatments of lung cancer and to support best practice learning across the community.


All virtual meetings will run from 6.30pm – 7.30pm

Tuesday 30 July 2019 | Session 1

Fast Progressing NSCLC patients and immunotherapy – what to do? – Dr Tim Benepal

In this session, Dr. Tim Benepal, Consultant Medical  Oncologist at St. George’s Hospital, will discuss the treatment of adult patients with locally advanced or metastatic NSCLC after prior chemotherapy.

The two year stopping rule, how to handle this conversation with patients and your team – Dr Brian Clark

In this session Dr. Brian Clark, Consultant Clincal Oncologist at the Beatson West of Scotland Cancer Centre, discusses his experiences of effectively communicating with patients, families and the wider MDT. Focusing on delivering bad news, patient consent, and the 2 year immunotherapy stopping rule. He will address questions such as:

  • ‘What needs to be included in these conversations?’
  • ‘How can you make sure that patients understand the two year stopping rule?’
Proposed date: Tuesday 10 September 2019 | Session 2

Details of speakers and topics will be released shortly

Proposed date: Monday 16 December 2019 | Session 3

Details of speakers and topics will be released shortly


Here are some of the speakers who will be attending the Virtual Lung Cancer Expert Forums:

Dr Tim Benepal

Consultant Medical Oncologist, St Georges NHS Trust

Read more

Dr Tim Benepal is a consultant medical oncologist at St George’s University Hospitals NHS Trust, London. He completed his medical training at University College Hospital, London in 1993. After working and training in general medicine for several years, he moved to the Chelsea & Westminster Hospital where he specialised in HIV medicine. Dr Benepal carried out his oncology training at the Royal Marsden, Guys and St Thomas’s Hospital, as well as a significant period of research in anti-folates, at The Institute of Cancer Research. He has been an oncologist for the last 22 years, the last 13 of which have been as a consultant at St George’s Hospital.

Dr Brian Clark

Consultant Clinical Oncologist, The Beatson West of Scotland Cancer Centre

Read more

Dr Brian Clark is a Consultant Clinical Oncologist at The Beatson West of Scotland Cancer Center and BMI Ross Hall Hospital in Glasgow. After graduating from The University of Glasgow in 1999, he spent several years training in general (internal) medicine, accident and emergency, psychiatry and clinical haematology. In 2005 he started training in clinical oncology. In 2009, he was appointed as a Fellow of the Royal College of Radiologists and was awarded the Rohan Williams Medal for his performance in the FRCR examination. He has since been heavily involved in the FRCR examinations, has been a member of the FRCR Clinical Oncology Part 2A Question Writing Group since 2009 and has co-chaired the Group since 2015. He is also a member of the FRCR Fellowship Examination Board. Since January 2017, Dr Clark has been the Lung Cancer Lead Clinician for Ayrshire and Arran.

Job code: RXUKATEZ00454d

This is a promotional meeting organised and funded by Roche Products Ltd.

July 2019

The link you have selected will take you away from this site to one that is not owned or controlled by Roche Products Ltd. Roche Products Ltd makes no representation as to the accuracy of the information contained on sites we do not own or control. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.